Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu 04/28/11 New York
VBI Progressing with Vaccines That Don’t Require Refrigeration 03/24/11 Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies 03/08/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities 09/16/10 Detroit
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions 09/15/10 Seattle
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences 08/16/10 Boston
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three 07/27/10 Seattle
Visterra, Previously Parasol, Expands with $6M 07/12/10 Boston
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
AVI Biopharma Gets $18M Flu Contract 06/07/10 Seattle
FDA OK’s IMDx H1N1 Test 03/24/10 Boston
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
The Top Five Biotech Innovations of the 2000s 12/15/09 Seattle
Quidel OKs $25M in Share Buybacks 12/08/09 San Diego
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters 11/10/09 Seattle
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic 11/03/09 Seattle
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego 10/27/09 San Diego
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Page 1 of 3 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.